Skip to main content
Contact Us
Subscribe
E-Edition
65°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IBB
Recent news which mentions IBB
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Look to SBIO for Biotech Exposure
December 12, 2022
Tickers
IBB
SBIO
XBI
Tags
SBIO
SS&C ALPS Advisors
State Street
From
ETF Trends
Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades'
December 05, 2022
Tickers
IBB
LVS
META
TSM
Tags
LVS
Jeffrey Mills
META
From
Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Tickers
AMGN
CHRS
CYTK
IBB
Tags
NVS
Government
chemotherapy
From
Benzinga
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 01, 2022
Tickers
BCTX
BCTXW
IBB
Tags
Penny Stocks
Market News
Partner Content
From
Benzinga
Chart of the Week: What Sector Looks Healthiest to Advisors
November 10, 2022
Tickers
IBB
RYH
SPY
VHT
Tags
Featured
RYH
expert insights
From
ETF Trends
‘Just so full of autocracies’: For the Freedom 100 Emerging Markets ETF, outperformance in 2022 goes beyond nixing China
November 03, 2022
Tickers
BUG
EEM
EMXC
EWW
Tags
KEMX
XCEM
IBB
From
MarketWatch
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
Tickers
APLS
ARDX
AZN
FOLD
Tags
Trading Ideas
IPSEY
SCYX
From
Benzinga
These 4 ETFs Feature on CNBC's 'Final Trades'
October 27, 2022
Tickers
HYG
IBB
JEPI
TBF
Tags
Markets
Virtus Investment Partners
Stephen Weiss
From
Benzinga
SBIO Rallied While Major Indexes Declined Last Week
October 04, 2022
Tickers
ALPS
FBT
IBB
SBIO
Tags
ALPS
spdr
ssga
From
ETF Trends
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Tickers
ALNY
AMLX
AZN
BLUE
Tags
SCPH
IBB
Top Stories
From
Benzinga
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
Tickers
AMGN
ASRT
BRK-A
BRK-B
Tags
Stocks to Buy
GILD
UNH
From
InvestorPlace
SBIO Outpaced XBI, IBB in Volatile Last Week
September 21, 2022
Tickers
IBB
SBIO
XBI
Tags
IBB
SS&C
ALPS
From
ETF Trends
Biden signs executive order targeting biotech as he talks up ‘cancer moonshot’
September 12, 2022
Tickers
IBB
SPX
Tags
SPX
IBB
From
MarketWatch
The Best Biotech Stock to Own in September
September 06, 2022
Tickers
CRSP
IBB
VRTX
XBI
Tags
Market News
Recent Press Releases
XBI
From
Motley Fool
SBIO Was ALPS’ Top Performing ETF in August
September 01, 2022
Tickers
IBB
SBIO
XBI
Tags
ETF Building Blocks Channel
IBB
XBI
From
ETF Trends
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
XBI
FENC
JNJ
From
Benzinga
Biotech ETFs Are on the Mend
August 19, 2022
Tickers
IBB
XBI
Tags
IBB
State Street
Biotechnology
From
ETF Trends
SBIO Rallies on M&A Announcements
August 10, 2022
Tickers
FBT
IBB
SBIO
XBI
Tags
BlackRock
ETF Building Blocks Channel
XBI
From
ETF Trends
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Tickers
ADMP
AEMD
ALPN
ARDS
Tags
AEMD
IBB
BCDA
From
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Tickers
ARCT
AXSM
AYTU
AZN
Tags
General
AZN
IONS
From
Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Tickers
ACAD
AKBA
ALDX
AMRX
Tags
Movers
AKBA
Small Cap
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
IBB
PSTX
EIGR
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
MCRB
JAZZ
RGNX
From
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Tickers
ABBV
ACIU
ALLR
AXLA
Tags
IBB
ACIU
ALLR
From
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Tickers
ALXO
ARQT
AZN
BEAM
Tags
TXMD
ELDN
Earnings
From
Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
July 31, 2022
Tickers
ACAD
AMGN
AXSM
BGNE
Tags
Top Stories
IBB
Small Cap
From
Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
ABBV
IBRX
VNRX
From
Benzinga
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
July 28, 2022
Tickers
ABBV
ACER
ALNY
ARGX
Tags
ACER
Financing
Earnings
From
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Tickers
ALKS
ALVR
BMY
CDTX
Tags
Benzinga
CDTX
News
From
Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
July 26, 2022
Tickers
ABBV
ALPMF
ANGN
BIIB
Tags
LEGN
Financing
SGEN
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.